Arrowhead Pharmaceuticals revenue
Arrowhead Pharmaceuticals (ARWR) reported revenue of $450.82 M for fiscal year 2026, −45.6% compared with the year before. Over the last 12 months revenue was $450.82 M.
Revenue 2026$450.82 M
Change−45.6%
World rank#1179
Market cap$6.09 B
Revenue by year
By year
| Year | Value | Change |
|---|---|---|
| 2026 | $450.82 M | −45.6% |
| 2025 | $829.45 M | +23,258% |
| 2024 | $3.55 M | −98.5% |
| 2023 | $240.74 M | — |
Data: company filings via Yahoo Finance, updated 2026-11-19. Not investment advice.